Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Sales | 7,000 | 0 | 0 | 0 | 0 |
Gross Profit | 7,000 | N/A | N/A | N/A | N/A |
Operating Expenses | 13,248 | 12,481 | 48,211 | 16,411 | 17,649 |
Operating Income | -6,248 | -12,481 | -48,211 | -16,411 | -17,649 |
Interest Expense | 1,327 | 800 | 600 | 0 | 0 |
Other Income | 338 | 271 | 652 | -20 | 277 |
Pre-tax Income | -7,237 | -13,010 | -48,159 | -16,431 | -17,372 |
Net Income Continuous | -7,237 | -13,010 | -48,159 | -16,431 | -17,372 |
Net Income | $-7,237 | $-13,010 | $-48,159 | $-16,431 | $-17,372 |
EPS Basic Total Ops | -2.00 | -3.50 | -13.00 | -7.00 | -8.75 |
EPS Basic Continuous Ops | -1.95 | -3.51 | -13.04 | -7.25 | -8.73 |
EPS Diluted Total Ops | -2.00 | -3.50 | -13.00 | -7.00 | -8.75 |
EPS Diluted Continuous Ops | -1.95 | -3.51 | -13.04 | -7.25 | -8.73 |
EBITDA(a) | $-5,145 | $-11,151 | $-46,146 | $-14,339 | $-15,617 |